Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 70 years old (any gender).
- People who have been newly diagnosed with pancreatic cancer that has spread to the liver, confirmed by a tissue sample (biopsy) or medical assessment, and has not spread to any other organs.
- People whose tumours can be seen on imaging scans and can be safely reached with a needle or probe.
- People who have no more than 3 tumours in one half of the liver, with each tumour measuring 3 cm or smaller.
- People who are reasonably active and able to carry out daily activities (as measured by a standard medical scoring tool), with a life expectancy of more than 3 months.
Who may not be able to join:
- People whose liver is not functioning well, rated at the most severe level on a standard liver function scale, or who have serious yellowing of the skin or eyes, particularly caused by a blockage.
- People whose liver has shrunk significantly, or whose tumours are so large that treating them would require affecting more than one-third of the total liver.
- People with a life expectancy of less than 3 months.
- People with serious problems affecting the heart, lungs, liver, or kidneys, or who have difficulty with normal blood clotting.
- People with other health conditions that are not well controlled, such as high blood pressure, diabetes, an ongoing active infection, or a mental health or personal situation that may make it difficult to follow the study requirements.
- People with severe fluid build-up in the abdomen, around the lungs, or other problematic fluid accumulation.
- People who are pregnant or breastfeeding.
- People whom the trial researchers consider unsuitable for any other reason that could affect their participation in the study (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Long Jiang, MD, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phone: 18017317460
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety and efficacy assessment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.